September 16, 2025

Lebrikizumab 24-Week Trial in Skin of Color Atopic Dermatitis

Lebrikizumab shows sustained efficacy across Fitzpatrick IV–VI at 24 weeks in atopic dermatitis.

Conexiant

September 16, 2025

Lateral Positioning Reduced Hypoxaemia After Anesthesia

Lateral positioning shortens PACU stay and lowers airway intervention rates in sedated adults.

Conexiant

September 15, 2025

FDA Approves First Intranasal Loop Diuretic

The FDA has approved Enbumyst offering a self-administered outpatient option for managing edema in patients with heart failure, liver disease, and kidney disease.

Conexiant

September 15, 2025

1 in 5 US Med Students Food Insecure, Study

Loans, debt, and dependents drove food insecurity among US medical students.

Conexiant

September 15, 2025

New Insights into Duodenal Neuroendocrine Tumor Profiles

Researchers identify expanded hormone and transcription factor profiles in duodenal neuroendocrine tumors.

Conexiant

September 12, 2025

Cemiplimab Reduces Recurrence in High-Risk cSCC

First adjuvant immunotherapy trial shows 23% absolute reduction in recurrence for resected cutaneous squamous cell carcinoma.

Conexiant

September 12, 2025

AI-Powered Proteomics Sharpens ALS Diagnosis

Researchers identified a biomarker panel predicting amyotrophic lateral sclerosis onset

The Pathologist

September 11, 2025

The Brutality of the Investment Landscape

Michael Murray has spent decades advising on deal management and commercial strategy – and he has a lot of tips and advice for budding start-ups looking for investment.

The Medicine Maker

September 09, 2025

Merger Cure? Rural Hospitals Try Networks

Mobile magnetic resonance imaging units and rural hospital networks support independent hospitals in improving access to diagnostic imaging and patient care in underserved areas.

KFF Health News